[go: up one dir, main page]

CN115725620B - Method for synthesizing panax japonicus saponins in pseudo-ginseng cells - Google Patents

Method for synthesizing panax japonicus saponins in pseudo-ginseng cells Download PDF

Info

Publication number
CN115725620B
CN115725620B CN202211106516.5A CN202211106516A CN115725620B CN 115725620 B CN115725620 B CN 115725620B CN 202211106516 A CN202211106516 A CN 202211106516A CN 115725620 B CN115725620 B CN 115725620B
Authority
CN
China
Prior art keywords
panax notoginseng
saponin
cells
pnds
pseudo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211106516.5A
Other languages
Chinese (zh)
Other versions
CN115725620A (en
Inventor
葛锋
胡泽群
陈勤
王志龙
刘迪秋
崔秀明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming University of Science and Technology
Original Assignee
Kunming University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming University of Science and Technology filed Critical Kunming University of Science and Technology
Priority to CN202211106516.5A priority Critical patent/CN115725620B/en
Publication of CN115725620A publication Critical patent/CN115725620A/en
Application granted granted Critical
Publication of CN115725620B publication Critical patent/CN115725620B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a method for synthesizing panax japonicus saponins in pseudo-ginseng cells, which comprises the following steps of constructingPnDSGene RNAi expression vector and method for introducing the same into pseudo-ginseng cells to obtain synthetic panax japonicus soapThe nucleotide sequence of the RNAi fragment of the notoginseng cell of the glycoside is shown as SEQ ID NO. 1; the method can inhibit the first key enzyme gene related to dammarane type triterpene saponin synthesis branch in Notoginseng radix saponin biosynthesis pathway from reverse regulation point of viewPnDSThe expression of the dammarane type triterpenoid saponin is reduced, so that the pseudo-ginseng cells are promoted to synthesize the oleanane type saponin which is not originally contained, namely the panax japonicus saponin.

Description

一种在三七细胞中合成竹节参皂苷的方法A method for synthesizing bamboo ginseng saponins in Panax notoginseng cells

技术领域Technical field

本发明属于皂苷合成技术领域,具体涉及一种在三七细胞中合成竹节参皂苷的方法。The invention belongs to the technical field of saponin synthesis, and specifically relates to a method for synthesizing bamboo saponins in Panax notoginseng cells.

背景技术Background technique

五加科(Araliaceae)人参属(Panax)包括多种药用植物,其中人参(Panaxginseng)、西洋参(Panax quinquefolius)、三七(Panax notoginseng)和珠子参(Panaxjaponicus)应用最为广泛。它们的主要活性成分为三萜皂苷,具有防治心脑血管疾病、抗疲劳、抗氧化、增强免疫力以及保肝护肝等多种药理功效。人参属药用植物三萜皂苷生物合成途径在起始阶段、骨架构建阶段基本相同,各物种间皂苷合成的主要差异在于2,3-氧化鲨烯形成后,以2,3-氧化鲨烯为共同前体,分别出现了两条独立的三萜皂苷合成支路。2,3-氧化鲨烯经达玛烯二醇合成酶(DS)催化,进入达玛烷型皂苷合成分支;经β-香树脂醇合成酶(β-AS)催化,则进入齐墩果烷型皂苷合成分支。The Panax genus of the Araliaceae family includes a variety of medicinal plants, among which Panaxginseng, Panax quinquefolius, Panax notoginseng and Panaxjaponicus are the most widely used. Their main active ingredient is triterpene saponins, which have various pharmacological effects such as preventing and treating cardiovascular and cerebrovascular diseases, anti-fatigue, antioxidant, enhancing immunity, and protecting the liver. The biosynthetic pathways of triterpenoid saponins in medicinal plants of the genus Ginseng are basically the same in the initial stage and skeleton construction stage. The main difference in saponin synthesis between species is that after the formation of 2,3-oxysqualene, 2,3-oxysqualene is used as the From the common precursor, two independent triterpene saponin synthesis branches emerged. 2,3-Oxisqualene is catalyzed by dammarenediol synthase (DS) and enters the dammarane-type saponin synthesis branch; catalyzed by β-amyrin alcohol synthase (β-AS), it enters oleanane Type saponin synthesis branch.

迄今为止,从人参属药材分离出的三萜皂苷主要为达玛烷型皂苷,人参、西洋参、珠子参均含有达玛烷型和齐墩果烷型两种类型的三萜皂苷,但三七只含达玛烷型皂苷,不能够合成齐墩果烷型皂苷,这是三七有别于其他人参属物种的特点。目前已知,竹节参皂苷Ⅳ、竹节参皂苷Ⅳa属于齐墩果烷型皂苷,自然状态下的三七不具有合成竹节参皂苷Ⅳ、竹节参皂苷Ⅳa的能力。So far, the triterpene saponins isolated from Panax genus medicinal materials are mainly dammarane saponins. Ginseng, American ginseng, and ginseng all contain two types of triterpene saponins: dammarane type and oleanane type, but notoginseng It only contains dammarane-type saponins and cannot synthesize oleanane-type saponins. This is the characteristic that distinguishes Panax notoginseng from other ginseng species. It is currently known that bamboo saponin IV and bamboo saponin IVa are oleanane-type saponins, and Panax notoginseng in the natural state does not have the ability to synthesize bamboo saponin IV and bamboo saponin IVa.

发明内容Contents of the invention

针对现有技术的不足,本发明提供了一种在三七细胞中合成竹节参皂苷的方法,该方法通过构建PnDS基因RNAi表达载体,并将其转入三七细胞中,抑制三七中达玛烷型三萜皂苷合成支路的第一个关键酶PnDS基因的表达,弱化达玛烷型皂苷合成支路代谢流量,促使三七细胞合成竹节参皂苷,其中RNAi片段的核苷酸序列如SEQ ID NO:1所示;In view of the shortcomings of the existing technology, the present invention provides a method for synthesizing ginseng saponins in Panax notoginseng cells. This method constructs a PnDS gene RNAi expression vector and transfers it into Panax notoginseng cells to inhibit Panax notoginseng. The expression of the PnDS gene, the first key enzyme of the dammarane-type triterpene saponin synthesis branch, weakens the metabolic flow of the dammarane-type triterpene saponin synthesis branch and promotes Panax notoginseng cells to synthesize bamboo saponins, in which the nucleotides of the RNAi fragment The sequence is shown in SEQ ID NO:1;

本发明目的通过以下技术方案实现:The object of the present invention is achieved through the following technical solutions:

1、从三七根部提取总RNA,逆转录合成三七cDNA,以合成的第一链cDNA为模板,通过PCR扩增PnDS基因干扰片段,其中基因PnDS的核苷酸序列如SEQ ID NO:1所示;1. Extract total RNA from the roots of Panax notoginseng, synthesize Panax notoginseng cDNA by reverse transcription, and use the synthesized first-strand cDNA as a template to amplify the PnDS gene interference fragment by PCR. The nucleotide sequence of the gene PnDS is as SEQ ID NO: 1 shown;

2、构建PnDS基因RNAi干扰载体pHellsagte-PnDS,转化农杆菌,通过PCR筛选出阳性单克隆;2. Construct the PnDS gene RNAi interference vector pHellsagte-PnDS, transform Agrobacterium, and screen out positive single clones through PCR;

3、利用农杆菌介导的遗传转化法,将pHellsagte-PnDS导入三七细胞表达,通过抗生素筛选和qRT-PCR筛选阳性转基因细胞系;3. Use Agrobacterium-mediated genetic transformation method to introduce pHellsagte-PnDS into Panax notoginseng cells for expression, and screen positive transgenic cell lines through antibiotic screening and qRT-PCR;

4、提取三七转基因细胞和非转基因细胞系中的皂苷,分析转基因细胞和非转基因细胞系间皂苷的种类和含量的差异。4. Extract saponins from Panax notoginseng transgenic cells and non-transgenic cell lines, and analyze the differences in types and contents of saponins between transgenic cells and non-transgenic cell lines.

本发明的优点和技术效果:Advantages and technical effects of the present invention:

本发明为生产竹节参皂苷Ⅳa、竹节参皂苷Ⅳ提供了一种新方法,竹节参皂苷Ⅳa、竹节参皂苷Ⅳ是珠子参的主要活性成分,属于典型的齐墩果烷型皂苷,在三七药材中不含有。本发明通过基因调控方法在三七细胞中合成竹节参皂苷Ⅳa、竹节参皂苷Ⅳ,在种间实现了皂苷的异源表达,且本发明方法简单,易操作,具有工业化生产和市场推广应用的潜力。The invention provides a new method for producing bamboo ginseng saponin IVa and bamboo ginseng saponin IV. Bamboo ginseng saponin IVa and bamboo ginseng saponin IV are the main active ingredients of ginseng and are typical oleanane-type saponins. , not contained in Panax notoginseng medicinal materials. The present invention synthesizes Bamboo ginseng saponin IVa and Bamboo ginseng saponin IV in Panax notoginseng cells through gene regulation methods, thereby realizing heterologous expression of saponins among species. The method of the present invention is simple, easy to operate, and has the potential for industrial production and marketing. application potential.

附图说明Description of the drawings

图1为RNAi片段序列扩增结果;Figure 1 shows the RNAi fragment sequence amplification results;

图2为带attB重组位点的RNAi片段扩增产物,其中1:RNAi片段,M:MarkerDL2501;Figure 2 shows the amplification product of RNAi fragment with attB recombination site, where 1: RNAi fragment, M: MarkerDL2501;

图3为pHellsagte-PnDS载体转入大肠杆菌DH5α的鉴定电泳图,其中1-8:菌液样品,M:MarkerDL2501,+:pHellsagte-PnDS质粒,-:阴性对照;Figure 3 is the identification electrophoresis diagram of pHellsagte-PnDS vector transferred into E. coli DH5α, in which 1-8: bacterial liquid sample, M: MarkerDL2501, +: pHellsagte-PnDS plasmid, -: negative control;

图4为pHellsagte-PnDS载体转入农杆菌LBA4404的鉴定电泳图,其中1-5:菌液样品;M:MarkerDL2502;-:阴性对照;Figure 4 is the identification electrophoresis diagram of pHellsagte-PnDS vector transferred into Agrobacterium LBA4404, in which 1-5: bacterial liquid sample; M: MarkerDL2502; -: negative control;

图5为PCR检测转基因三七细胞的电泳图,其中1-6:转基因三七细胞系,M:MarkerDL2502;Figure 5 shows the electrophoresis pattern of PCR detection of transgenic Panax notoginseng cells, in which 1-6: transgenic Panax notoginseng cell line, M: MarkerDL2502;

图6为实为时荧光定量PCR检测转基因三七细胞中PnDS基因以及5个与竹节参皂苷Ⅳa、竹节参皂苷Ⅳ合成相关的基因相对表达量的检测结果,其中WT为野生型细胞系,T1~T4为4个PnDS基因的转基因三七细胞系;Figure 6 shows the detection results of real-time fluorescence quantitative PCR detection of the PnDS gene and five genes related to the synthesis of bamboo saponin IVa and bamboo saponin IV in transgenic Panax notoginseng cells, in which WT is a wild-type cell line. , T1 to T4 are transgenic Panax notoginseng cell lines with 4 PnDS genes;

图7为转基因三七细胞系中皂苷含量图,其中WT为野生型三七参细胞系,T1-T4为转基因三七参细胞系)。Figure 7 shows the saponin content in the transgenic Panax notoginseng cell line, in which WT is the wild-type Panax notoginseng cell line, and T1-T4 is the transgenic Panax notoginseng cell line).

具体实施方式Detailed ways

下面通过实施例对本发明作进一步详细说明,但本发明保护范围不局限于所述内容,实施例中方法如无特殊说明均为常规方法,使用的试剂如无特殊说明均为常规市售试剂或按常规方法配制的试剂。The present invention will be further described in detail below through examples, but the scope of protection of the present invention is not limited to the content described. The methods in the examples are all conventional methods unless otherwise stated, and the reagents used are all conventional commercially available reagents or Reagents prepared according to conventional methods.

实施例1:PnDS基因的RNAi片段的克隆Example 1: Cloning of RNAi fragment of PnDS gene

(1)三七总RNA的提取(1) Extraction of total RNA from Panax notoginseng

本发明采用改良的异硫氰酸胍法提取三七愈伤组织总RNA,具体操作如下:将研钵、研钵棒进行去RNA酶、高温干热灭菌处理后,冷却至室温。称取适量三七愈伤组织细胞置于处理过的研砵中,利用液氮将三七愈伤组织研磨成粉末,加入10%(w/v)预冷的RNA提取缓冲液和1.0%(w/v)的β-巯基乙醇,充分研磨。取1.0mL研磨液转移至2mL的离心管中,加入500μL RNA提取酚、100μL氯仿以及1/10体积的2M醋酸钠溶液(pH为4.0),剧烈振荡混匀,冰上静置5min后于4℃、12500g离心15min,缓慢吸取上清液转移至新的2mL离心管中,加入1:1等体积的RNA提取酚/氯仿,剧烈震荡混匀,冰上静置5min后,4℃、12500g离心15min(重复此步骤至中间层几乎消失)。缓慢吸取上清液转移至新的2mL离心管中,加入等体积的氯仿,剧烈震荡混匀,冰上静置5min,4℃、12500g离心15min,缓慢吸取上清液转移至新的1.5mL的离心管中,加入1/10体积的3M醋酸钠溶液(pH为5.2),再加入等体积异丙醇,缓慢颠倒混匀,于-20℃静置1.5h充分沉淀后,4℃、12500g离心25min;弃上清液,用75%的乙醇溶液吹打洗涤沉淀,两次吹打洗涤后,使用移液枪吸掉液体并置于超净工作台进行风干,至乙醇挥发彻底后,加入15-30μL RNaes的水溶解RNA沉淀。琼脂糖凝胶电泳检测所提三七愈伤组织细胞总RNA完整性,然后用紫外分光光度计检测所提RNA的浓度和纯度。The present invention adopts an improved guanidinium isothiocyanate method to extract total RNA from Panax notoginseng callus. The specific operation is as follows: the mortar and mortar rod are subjected to RNase removal and high-temperature dry heat sterilization, and then cooled to room temperature. Weigh an appropriate amount of Panax notoginseng callus cells and place them in a treated pestle. Use liquid nitrogen to grind the Panax notoginseng callus into powder. Add 10% (w/v) pre-cooled RNA extraction buffer and 1.0% ( w/v) of β-mercaptoethanol and grind thoroughly. Transfer 1.0 mL of the grinding solution to a 2 mL centrifuge tube, add 500 μL RNA extraction phenol, 100 μL chloroform and 1/10 volume of 2M sodium acetate solution (pH 4.0), shake vigorously to mix, and let stand on ice for 5 minutes before adding 4 Centrifuge at 12500g for 15 minutes at ℃, slowly transfer the supernatant to a new 2mL centrifuge tube, add 1:1 equal volume of RNA extraction phenol/chloroform, shake vigorously to mix, let stand on ice for 5 minutes, and centrifuge at 4℃ and 12500g 15min (repeat this step until the middle layer almost disappears). Slowly absorb the supernatant and transfer it to a new 2mL centrifuge tube, add an equal volume of chloroform, shake vigorously and mix, let stand on ice for 5 minutes, centrifuge at 4°C and 12500g for 15 minutes, slowly absorb the supernatant and transfer it to a new 1.5mL centrifuge tube. In the centrifuge tube, add 1/10 volume of 3M sodium acetate solution (pH 5.2), then add an equal volume of isopropanol, mix slowly by inverting, let stand at -20°C for 1.5h, and after sufficient precipitation, centrifuge at 4°C and 12500g 25 minutes; discard the supernatant and pipet and wash the precipitate with 75% ethanol solution. After two pipetting and washing, use a pipette to suck off the liquid and place it on a clean workbench for air drying. After the ethanol has completely evaporated, add 15-30 μL RNaes dissolve RNA pellet in water. The integrity of the total RNA extracted from Panax notoginseng callus cells was detected by agarose gel electrophoresis, and then the concentration and purity of the extracted RNA were detected using a UV spectrophotometer.

(2)cDNA第一链的合成(2)Synthesis of the first strand of cDNA

选取质量较好的RNA利用Promega公司的GoScript反转录系统合成cDNA第一链,首先将Oligo(dT)15 1.0μL、总RNA5.0μg、Nuclease-free Water补至10μL充分温和混匀,并将其置于70℃水浴锅中水浴5min进行预变性,然后立即置于冰上冰浴5min,再加入如下试剂:Nuclease-free Water 1.6μL、GoScriptTM5×Reaction Buffer 4.0μL、PCR NucleotideMix 1.0μL、MgCl2(25mM)2.0μL、RecombinantRibonuclease Inhibitor 0.4μL、GoScriptTMReverse Transcriptase 1.0μL,混匀,瞬时离心,25℃退火5min,42℃水浴延伸90min,最后,放置70℃水浴锅中水浴15min,终止逆转录酶活性,即得三七cDNA第一链。Select RNA with better quality and use Promega's GoScript reverse transcription system to synthesize the first strand of cDNA. First, add 1.0 μL of Oligo(dT) 15 , 5.0 μg of total RNA, and Nuclease-free Water to 10 μL and mix thoroughly and gently. Place it in a 70°C water bath for 5 minutes for pre-denaturation, then immediately place it on ice for 5 minutes, then add the following reagents: Nuclease-free Water 1.6μL, GoScript TM 5×Reaction Buffer 4.0μL, PCR NucleotideMix 1.0μL, MgCl 2 (25mM) 2.0μL, Recombinant Ribonuclease Inhibitor 0.4 μL, GoScript TM Reverse Transcriptase 1.0 μL, mix well, centrifuge briefly, anneal at 25°C for 5 minutes, extend in a water bath at 42°C for 90 minutes, and finally, place in a 70°C water bath for 15 minutes to terminate the reverse transcriptase activity to obtain Panax notoginseng. cDNA first strand.

(3)RNAi片段的合成(3)Synthesis of RNAi fragments

根据三七PnDS基因全长序列(KJ804174.1),利用PrimerPremier5.0设计其特异性引物PnDSF:5’-TCCCCTTATCATTGCCCT-3’和PnDSR:5’-GCTTTTTCCCCATTTCCT-3’,以上述获得的三七cDNA第一链为模板,在DNA聚合酶Ex Taq的作用下进行高保真PCR扩增,PCR反应条件:98℃、3min;98℃、10s,60℃、15s,72℃、15s,35cycles;72℃、5min;将获得的扩增产物于1%的琼脂糖凝胶电泳进行分离,回收片段为基因PnDS的第503-1246位核苷酸序列;According to the full-length sequence of Panax notoginseng PnDS gene (KJ804174.1), use PrimerPremier5.0 to design its specific primers PnDS F : 5'-TCCCCTTATCATTGCCCT-3' and PnDS R : 5'-GCTTTTTCCCCATTTCCT-3', using the three obtained above The first strand of seven cDNA is used as a template, and high-fidelity PCR amplification is performed under the action of DNA polymerase Ex Taq. PCR reaction conditions: 98°C, 3min; 98°C, 10s, 60°C, 15s, 72°C, 15s, 35cycles; 72°C, 5 min; separate the amplified product obtained by 1% agarose gel electrophoresis, and the recovered fragment is the 503-1246th nucleotide sequence of the gene PnDS;

目的片段回收后与pGEM T-easy载体连接,转入大肠杆菌DH5α,随机挑选平板上的单菌落,进行菌液PCR扩增,检测阳性克隆。将菌液PCR检测为阳性的单克隆送测序,利用NCBI中Blast软件将测序后的序列和三七PnDS基因序列进行比对,结果见图1,核苷酸序列如SEQ ID NO:1所示,比对结果正确,将结果正确的大肠杆菌单克隆接种于含有壮观霉素的液体LB培养基中扩培,37℃、200rpm振荡培养15h,使用SanPrep柱式质粒抽提试剂盒提取质粒(T-PnDS)。After the target fragment is recovered, it is connected to the pGEM T-easy vector and transferred into E. coli DH5α. Single colonies on the plate are randomly selected and amplified by bacterial liquid PCR to detect positive clones. The single clones that were positive in the bacterial liquid PCR test were sent for sequencing, and the sequenced sequence was compared with the Panax notoginseng PnDS gene sequence using the Blast software in NCBI. The results are shown in Figure 1. The nucleotide sequence is shown in SEQ ID NO: 1. , the comparison result is correct, inoculate the E. coli single clone with the correct result into the liquid LB medium containing spectinomycin and expand it, culture it with shaking at 37°C and 200 rpm for 15 hours, and use the SanPrep column plasmid extraction kit to extract the plasmid (T -PnDS).

实施例2:PnDS基因RNAi表达载体的构建Example 2: Construction of PnDS gene RNAi expression vector

(1)连有attB重组位点的RNAi片段的克隆(1) Cloning of RNAi fragments connected to attB recombination site

根据GatewayTM的技术原理,设计引物BP-CF(5’-GGGGACAAGTTTGTACAAAAAAGCAGG CTTCCCCTTATCATTGCCCT-3’)和BP-CR(5’-GGGGACCACTTTGTACAAGAAAGCTGGGTGCTTTTTCCCCATTTCCT-3’)(下划线部分为attB重组位点),采用PCR手段将接头加到RNAi片段两端,使得目的片段与载体发生同源重组反应,以上述抽提的质粒为模板,BP-CF/BP-CR为引物,用Ex Taq进行attB-PCR扩增,PCR反应条件与实施例1步骤(3)中相同,此次扩增后,RNAi片段两侧均接上了attB重组位点;胶回收PCR产物,结果见图2;According to the technical principle of GatewayTM, the primers BP-C F (5'-GGGG ACAAGTTTGTACAAAAAAGCAGG CT TCCCCTTATCATTGCCCT-3') and BP-C R (5'-GGGG ACCACTTTGTACAAGAAAGCTGGGT GCTTTTTCCCCATTTCCT-3') were designed (the underlined part is the attB recombination site), Use PCR to add adapters to both ends of the RNAi fragment, allowing a homologous recombination reaction between the target fragment and the vector. Use the above extracted plasmid as a template, BP-C F /BP- CR as primers, and use Ex Taq to perform attB- PCR amplification, the PCR reaction conditions were the same as in step (3) of Example 1. After this amplification, attB recombination sites were connected to both sides of the RNAi fragment; the PCR product was recovered by gel, and the results are shown in Figure 2;

(2)PnDS基因RNAi表达载体的构建(2) Construction of PnDS gene RNAi expression vector

依据BP ClonaseTMII Enzyme Mix试剂盒说明书进行RNAi载体的构建,反应体系设置如下:attB-PCR胶回收产物0.15μg、pHellsagte 2载体质粒0.15μg、BPClonaseTMII Enzyme Mix 2.00μL、TE缓冲液(pH=8.0)补至10μL;依次加入上述溶液,用移液枪吹打混匀,置于25℃水浴锅中水浴,反应4h,然后向反应液中加入1μL蛋白酶K,37℃水浴锅中水浴10min,终止反应,反应产物转化大肠杆菌感受态细胞,挑取单克隆,单克隆PCR验证结果见图3,对其进行扩大培养,随后进行质粒(pHellsgate-PnDS)抽提;对得到的质粒分别用限制性内切酶XbaI和XhoI进行单酶切,酶切体系如下:pHellsagte-PnDS质粒5.0μg、10×Buffer2.0μL、限制性内切酶XbaⅠ/XhoⅠ1.5μL、ddH2O水补至20μL;in accordance with BP Clonase TM II Enzyme Mix kit instructions are used to construct RNAi vectors. The reaction system settings are as follows: attB-PCR gel recovery product 0.15 μg, pHellsagte 2 vector plasmid 0.15 μg, BPClonase TM II Enzyme Mix 2.00 μL, TE buffer (pH= 8.0) Make up to 10 μL; add the above solutions in sequence, pipet and mix with a pipette, place in a 25°C water bath, react for 4 hours, then add 1 μL of proteinase K to the reaction solution, and wait in a 37°C water bath for 10 minutes to terminate. reaction, the reaction product was transformed into Escherichia coli competent cells, single clones were selected, the single clone PCR verification results are shown in Figure 3, they were expanded and cultured, and then the plasmid (pHellsgate-PnDS) was extracted; the obtained plasmids were used with restriction Endonucleases XbaI and XhoI were used for single enzyme digestion. The enzyme digestion system was as follows: pHellsagte-PnDS plasmid 5.0 μg, 10×Buffer 2.0 μL, restriction endonuclease XbaⅠ/XhoⅠ 1.5 μL, and ddH 2 O water was added to 20 μL;

酶切体系置于37℃水浴锅中进行5h的酶切反应,反应结束后,酶切产物经1%琼脂糖凝胶电泳检测,根据两种酶的酶切产物跑胶条带大小判断PnDS基因RNAi表达载体pHellsagte-PnDS构建成功;然后通过液氮冻融法将载体转入农杆菌LBA4404感受态细胞中,同时将空载pHellsagte 2也转化到LBA4404感受态细胞中,作为空载对照,结果见图4,从图中可以看出所扩增出来的条带约为750bp,符合预期,表明PnDS因的RNAi片段已经成功转化到农杆菌中。The enzyme digestion system was placed in a 37°C water bath for 5 hours of enzyme digestion reaction. After the reaction, the enzyme digestion products were detected by 1% agarose gel electrophoresis. The PnDS gene was judged based on the size of the gel bands of the enzyme digestion products of the two enzymes. The RNAi expression vector pHellsagte-PnDS was successfully constructed; the vector was then transformed into Agrobacterium LBA4404 competent cells by liquid nitrogen freezing and thawing. At the same time, the empty pHellsagte 2 was also transformed into LBA4404 competent cells as an empty control. The results are shown in Figure 4. It can be seen from the figure that the amplified band is about 750 bp, which is in line with expectations, indicating that the RNAi fragment of the PnDS gene has been successfully transformed into Agrobacterium.

实施例3:根癌农杆菌介导的三七遗传转化Example 3: Genetic transformation of Panax notoginseng mediated by Agrobacterium tumefaciens

1、三七细胞预培养1. Preculture of Panax notoginseng cells

(1)采集三七茎叶,使用三七愈伤组织培养基(MS培养基+2,4-D 2mg/L+KT 1mg/L,培养基pH5.6),培养条件为固体培养,温度25±1℃,避光培养,培养周期28天,获得的三七愈伤组织;将获得的三七愈伤组织采用含2,4-D 2mg/L、KT 2mg/L的MS固体培养基继代培养15天,获得三七继代培养细胞;(1) Collect Panax notoginseng stems and leaves, use Panax notoginseng callus culture medium (MS medium + 2,4-D 2mg/L + KT 1mg/L, medium pH 5.6), the culture conditions are solid culture, temperature 25±1°C, cultured in the dark, with a culture period of 28 days, to obtain the callus of Panax notoginseng; use MS solid medium containing 2,4-D 2mg/L and KT 2mg/L to obtain the callus of Panax notoginseng. Subculture for 15 days to obtain Panax notoginseng subcultured cells;

(2)选取生长状态良好的三七参愈伤组织细胞转接于三七愈伤组织细胞预培养基(在三七愈伤组织培养基中添加乙酰丁香酮至40mg/L)上,平铺覆盖培养基整个表面,并置于25℃条件下暗培养3天;(2) Select Panax notoginseng callus cells in good growth status and transfer them to the Panax notoginseng callus cell pre-culture medium (add acetosyringone to the Panax notoginseng callus culture medium to 40 mg/L), and spread them flat. Cover the entire surface of the culture medium and culture it in the dark at 25°C for 3 days;

(2)三七细胞侵染(2) Panax notoginseng cell infection

吸取100-200μL携带PnDS基因RNAi表达载体质粒pHellsagte-PnDS的活化好的LBA4404农杆菌菌液涂布于含50mg/L卡那霉素和25mg/L利福平的LB固体培养基平板上(该步骤可与三七愈伤组织细胞预培养同时进行),在28℃培养箱中倒置培养2-3天,至平板长满一层厚厚的菌。用接种针刮取一定大小的生长好的菌团于含40mg/L乙酰丁香酮的MGL液体培养基中,于28℃、200rpm摇床振荡培养至菌液OD600为0.6-0.8,接入上述预培养3天的三七愈伤组织细胞中,使三七愈伤组织细胞完全浸没于菌液中,于25℃、105rpm摇床上振荡培养20min;Pipette 100-200 μL of the activated LBA4404 Agrobacterium bacterial liquid carrying the PnDS gene RNAi expression vector plasmid pHellsagte-PnDS and spread it on the LB solid medium plate containing 50 mg/L kanamycin and 25 mg/L rifampicin (the This step can be performed at the same time as the pre-culture of Panax notoginseng callus cells). Incubate upside down in a 28°C incubator for 2-3 days until the plate is covered with a thick layer of bacteria. Use an inoculation needle to scrape a certain size of the grown bacterial mass into MGL liquid culture medium containing 40 mg/L acetosyringone, and culture it with shaking on a shaking table at 28°C and 200 rpm until the OD 600 of the bacterial liquid is 0.6-0.8, and then connect to the above In the Panax notoginseng callus cells pre-cultured for 3 days, the Panax notoginseng callus cells were completely immersed in the bacterial solution, and cultured on a shaker at 25°C and 105 rpm for 20 minutes;

(3)细胞收集与共培养(3) Cell collection and co-culture

侵染结束后,用布氏漏斗对三七愈伤组织细胞进行抽滤,去除菌液,然后用无菌滤纸吸干三七愈伤组织细胞表面残余菌液,后将三七愈伤组织细胞转接至表面铺有无菌滤纸的三七共培养基上(防止农杆菌与培养基直接接触,导致农杆菌过度生长),放置于25℃黑暗条件下共培养3天,其中三七共培养基与三七愈伤组织细胞预培养基相同。After the infection, the Panax notoginseng callus cells were suction-filtered using a Buchner funnel to remove the bacterial liquid, and then the remaining bacterial liquid on the surface of the Panax notoginseng callus cells was sucked up with sterile filter paper, and then the Panax notoginseng callus cells were removed. Transfer to the Panax notoginseng co-culture medium with sterile filter paper on the surface (to prevent direct contact between Agrobacterium and the culture medium, resulting in overgrowth of Agrobacterium), and place it in a dark condition at 25°C for 3 days, in which Panax notoginseng co-culture The base is the same as the pre-culture medium of Panax notoginseng callus cells.

(4)除菌培养(4) Sterilization culture

共培养结束后,将三七愈伤组织细胞转移至已灭菌的烧杯中,用含有400mg/L头孢霉素的无菌水清洗5-6次,以充分去除农杆菌,清洗结束后用布氏漏斗对三七愈伤组织细胞进行抽滤,去除液体,然后用无菌滤纸吸干三七愈伤组织细胞表面残余液体。将三七愈伤组织细胞转接至除菌培养基(在三七愈伤组织培养基中添加头孢霉素和卡那霉素至终浓度为400mg/L和50mg/L)中,置于25℃、黑暗条件下进行15天的除菌培养。After the co-culture is completed, transfer the Panax notoginseng callus cells to a sterilized beaker and wash them 5-6 times with sterile water containing 400 mg/L cephalosporin to fully remove Agrobacterium. After cleaning, use a cloth The Panax notoginseng callus cells were suction-filtered using a funnel to remove the liquid, and then the remaining liquid on the surface of the Panax notoginseng callus cells was sucked up with sterile filter paper. Transfer the Panax notoginseng callus cells to sterilized medium (add cephalosporin and kanamycin to the Panax notoginseng callus medium to a final concentration of 400 mg/L and 50 mg/L) and place at 25 15 days of sterilization culture was carried out under dark conditions.

(5)筛选培养和继代(5) Screening, culture and subculture

除菌培养15天后,将三七愈伤组织细胞转接至三七愈伤组织筛选培养基(在三七愈伤组织培养基中添加卡那霉素至终浓度为50mg/L)上,大约35天左右继代一次(可根据生长情况调整继代周期),经过4-5次继代筛选,可获得具有卡那霉素抗性的PnDS基因RNAi转基因三七细胞系。After 15 days of sterilization and culture, the Panax notoginseng callus cells were transferred to the Panax notoginseng callus selection medium (add kanamycin to the Panax notoginseng callus medium to a final concentration of 50 mg/L), approximately Subculture once every 35 days (the subgeneration cycle can be adjusted according to growth conditions). After 4-5 subculture screenings, a PnDS gene RNAi transgenic Panax notoginseng cell line with kanamycin resistance can be obtained.

实施例4:转基因三七细胞中PnDS基因以及与竹节参皂苷合成相关的基因表达水平检测Example 4: Detection of expression levels of PnDS genes and genes related to saponin synthesis in transgenic Panax notoginseng cells

(1)转基因三七细胞系基因组DNA水平检测(1) Detection of genomic DNA level of transgenic Panax notoginseng cell line

采用改良的CTAB法提取转基因三七细胞系基因组DNA,根据pHellsagte 2载体中的T-DNA上卡那霉素npt II抗性基因序列设计上下游引物npt-F(5’-CTCTGATGCCGCCGTGTT-3’)和npt-R(5’-CCCTGATGCTCTTCGTCCA-3’),以所提三七基因组DNA为模板进行PCR检测,筛选阳性转基因的三七细胞,结果如图5,图中均扩增出一条大小约为430bp的特异性条带,与预期大小相符,表明这六株三七转基因细胞系均已导入外源DNA并整合到了基因组DNA上稳定遗传,初步确定获得了PnDS基因RNAi转基因细胞系。The modified CTAB method was used to extract the genomic DNA of the transgenic Panax notoginseng cell line, and the upstream and downstream primers npt-F (5'-CTCTGATGCCGCCGTGTT-3') were designed based on the kanamycin npt II resistance gene sequence on the T-DNA in the pHellsagte 2 vector. and npt-R(5'-CCCTGATGCTCTTCGTCCA-3'), using the proposed Panax notoginseng genomic DNA as a template for PCR detection, and screening the positive transgenic Panax notoginseng cells. The results are shown in Figure 5. In the figure, a strip of approximately The specific band of 430 bp is consistent with the expected size, indicating that the six Panax notoginseng transgenic cell lines have introduced exogenous DNA and integrated it into the genomic DNA for stable inheritance. It is preliminarily confirmed that the PnDS gene RNAi transgenic cell lines have been obtained.

(2)转基因三七细胞荧光定量PCR检测(2) Fluorescence quantitative PCR detection of transgenic Panax notoginseng cells

提取阳性转基因三七细胞株和非转基因三七细胞株的总RNA,反转录成cDNA,具体操作步骤与实施例1中相同;Extract the total RNA of the positive transgenic Panax notoginseng cell line and the non-transgenic Panax notoginseng cell line, and reverse-transcribe it into cDNA. The specific operation steps are the same as in Example 1;

根据18S rRNA基因(登录号:D85171.1)、β-香树脂醇合成酶(β-amysyrinsynthase,β-AS)基因(登录号:KP658156)、齐墩果酸合酶(Oleanic acidsynthase,CYP716A52v2)基因(登录号:JX036032.1)、齐墩果酸葡萄糖醛酸基转移酶(oleanolic acid glucuronosyltra nsferase,OAGT)基因(登录号:MH819287.1)、PjmUGT1基因和PjmUGT2基因设计用于荧光定量PCR的引物:18S-F:5’-GGGGAGTATGGTCGCAAGG-3’,18S-R:5’-CAGAACAT CTAAGGGCATCACAG-3’;β-AS-F:5’-GTATTCCCTGTAGAGCATCGCAT-3’,β-AS-R:5’-GGCACAGGCGTTGTTTTCAC-3’;CYP716A52v2-F:5’-AGGAGCAAATGGAGATAGTGA-3’,CYP716A52v2-R:5’-GATTGAGAAACCGTTGTAGG-3’;OAGT-F:5’-GCATAATCTCGGACA AGTAC-3’,OAGT-R:5’-AAAGGTTGGGAGTCTGAAGT-3’;PjmUGT1-F:5’-TCACATAAA TCCGATGGTCC-3’,PjmUGT1-R:5’-AGAAATCCCTGAAATCCTCC-3’;PjmUGT2-F:5’-GC ATTCTCCCTTTGTTTCAG-3’,PjmUGT2-R:5’-CGACTTGCCTCACTCTTCCT-3’。反转录合成的cDNA稀释5倍,即将20μL cDNA稀释至100μL。以系稀释后的cDNA为模板,采用上述荧光定量PCR的引物进行荧光定量PCR,根据qPCRMaster Mix说明书进行操作,每个样品对应的每个基因重复检测3次。利用2-ΔΔCt法对荧光定量数据进行处理,分析检测PnDS基因在转基因三七细胞系中相对于未转基因三七细胞系中的相对表达量,结果见图6,结果显示,在选取的T1-T4四株转基因三七细胞株系中关键酶PnDS基因的表达量明显低于普通三七细胞系,而与竹节参皂苷Ⅳa、竹节参皂苷Ⅳ合成相关的基因β-AS、CYP716A52v2、OAGT、PjmUGT1和PjmUGT2相对表达量明显高于普通三七细胞系。According to the 18S rRNA gene (accession number: D85171.1), β-amysyrinsynthase (β-AS) gene (accession number: KP658156), oleanolic acid synthase (Oleanic acidsynthase, CYP716A52v2) gene (Accession number: JX036032.1), oleanolic acid glucuronosyltra nsferase (OAGT) gene (Accession number: MH819287.1), PjmUGT1 gene and PjmUGT2 gene to design primers for fluorescence quantitative PCR : 18S-F: 5'-GGGGAGTATGGTCGCAAGG-3', 18S-R: 5'-CAGAACAT CTAAGGGCATCACAG-3'; β-AS-F: 5'-GTATTCCCTGTAGAGCATCGCAT-3', β-AS-R: 5'-GGCACAGGCGTTGTTTTCAC -3'; CYP716A52v2-F: 5'-AGGAGCAAATGGAGATAGTGA-3', CYP716A52v2-R: 5'-GATTGAGAAACCGTTGTAGG-3'; OAGT-F: 5'-GCATAATCTCGGACA AGTAC-3', OAGT-R: 5'-AAAGGTTGGGAGTCTGAAGT- 3'; PjmUGT1-F: 5'-TCACATAAA TCCGATGGTCC-3', PjmUGT1-R: 5'-AGAAATCCCTGAAATCCTCC-3'; PjmUGT2-F: 5'-GC ATTCTCCCTTTGTTTCAG-3', PjmUGT2-R: 5'-CGACTTGCCTCACTCTTCCT- 3'. The cDNA synthesized by reverse transcription was diluted 5 times, that is, 20 μL cDNA was diluted to 100 μL. Use the diluted cDNA as a template and use the above primers for fluorescence quantitative PCR. According to Follow the instructions of qPCRMaster Mix and repeat the detection three times for each gene corresponding to each sample. The 2 -ΔΔCt method was used to process the fluorescence quantitative data, and the relative expression of the PnDS gene in the transgenic Panax notoginseng cell line compared to the non-transgenic Panax notoginseng cell line was analyzed and detected. The results are shown in Figure 6. The results show that in the selected T1- The expression level of the key enzyme PnDS gene in the four transgenic Panax notoginseng cell lines of T4 is significantly lower than that of the ordinary Panax notoginseng cell line, while the genes related to the synthesis of bamboo ginseng saponin IVa and bamboo ginseng saponin IV are β-AS, CYP716A52v2, and OAGT. , the relative expression levels of PjmUGT1 and PjmUGT2 were significantly higher than those of ordinary Panax notoginseng cell lines.

实施例5:转基因三七细胞中皂苷含量检测Example 5: Detection of saponin content in transgenic Panax notoginseng cells

(1)样品溶液的制备(1) Preparation of sample solution

收集实施例4步骤(1)的转基因三七细胞株系和普通三七细胞系的愈伤组织细胞,分别标上号后置于55℃烘箱中烘干(约12h),烘干后将其充分研磨成粉末,各称取0.5g的转基因和普通三七细胞系粉末,分别放置于50mL离心管中,各加入50mL的70%甲醇溶液并浸泡过夜,再利用超声波进行破碎处理(60W,超声4s,间歇2s)1.5~2.0h,直至三七细胞粉末充分破碎完毕,超声结束后,转移至离心机中4000rpm离心30min,收集上清液,并将上清液放置于50~55℃烘箱中进行烘干,烘干后,用10mL蒸馏水进行溶解,并用等体积的水饱合正丁醇萃取3次。收集萃取液,并将萃取液放置于50~55℃烘箱中进行烘干,烘干后用70%甲醇溶液进行溶解并定容至25mL,经0.45μM的微孔滤膜过滤后即为皂苷溶液。Collect the callus cells of the transgenic Panax notoginseng cell line and the ordinary Panax notoginseng cell line in step (1) of Example 4, mark them with numbers respectively and place them in a 55°C oven for drying (about 12 hours). After drying, Fully grind into powder, weigh 0.5g of transgenic and ordinary Panax notoginseng cell line powder respectively, place them in 50mL centrifuge tubes, add 50mL of 70% methanol solution to each and soak overnight, and then use ultrasonic waves for crushing treatment (60W, ultrasonic 4s, 2s interval) for 1.5~2.0h until the Panax notoginseng cell powder is fully broken. After ultrasonic, transfer to a centrifuge and centrifuge at 4000rpm for 30min. Collect the supernatant and place it in an oven at 50~55°C. Dry it. After drying, dissolve it with 10 mL of distilled water, and extract it three times with an equal volume of water-saturated n-butanol. Collect the extract and place it in an oven at 50-55°C for drying. After drying, dissolve it with 70% methanol solution and adjust the volume to 25 mL. After filtering through a 0.45 μM microporous membrane, the saponin solution is obtained. .

(2)高效液相色谱分析(2) High performance liquid chromatography analysis

利用HPLC检测转基因三七细胞中皂苷的种类及其含量,HPLC检测条件如下:色谱柱为Waters-XTerra-MS-C18(5μm,250mm×4.6mm,USA)。流动相为水和乙腈。梯度洗脱:0-20min,20%乙腈;20-30min,20%-35%乙腈;30-40min,35%乙腈;40-50min,35-40%乙腈;50-60min,40-100%乙腈。流速为1.0mL/min,柱温30℃,检测波长设置为203nm;结果见图7,结果显示经过转基因操作后的三七细胞中含有齐墩果烷型皂苷(竹节参皂苷Ⅳa、竹节参皂苷Ⅳ),而未改造的野生型三七细胞中不产生齐墩果烷型皂苷(竹节参皂苷Ⅳa、竹节参皂苷Ⅳ)。HPLC was used to detect the types and contents of saponins in transgenic Panax notoginseng cells. The HPLC detection conditions were as follows: the chromatographic column was Waters-XTerra-MS-C18 (5 μm, 250 mm × 4.6 mm, USA). The mobile phase was water and acetonitrile. Gradient elution: 0-20min, 20% acetonitrile; 20-30min, 20%-35% acetonitrile; 30-40min, 35% acetonitrile; 40-50min, 35-40% acetonitrile; 50-60min, 40-100% acetonitrile . The flow rate is 1.0mL/min, the column temperature is 30°C, and the detection wavelength is set to 203nm; the results are shown in Figure 7. The results show that the Panax notoginseng cells after transgenic operation contain oleanane-type saponins (Bamboo ginseng saponin IVa, Bamboo ginseng saponin IVa, Ginsenoside IV), while unmodified wild-type Panax notoginseng cells do not produce oleanane-type saponins (Bamboo ginseng saponin IVa, Bamboo ginseng saponin IV).

Claims (1)

1.一种在三七细胞中合成竹节参皂苷的方法,其特征在于:将干扰基因PnDS的RNAi片段转入三七细胞中获得合成竹节参皂苷的三七细胞,其中干扰基因PnDS的RNAi片段的核苷酸序列如SEQ ID NO:1所示;1. A method for synthesizing bamboo ginseng saponins in Panax notoginseng cells, characterized by: transferring the RNAi fragment of the interfering gene PnDS into Panax notoginseng cells to obtain Panax notoginseng cells that synthesize bamboo ginseng saponins, wherein the RNAi fragment of the interfering gene PnDS The nucleotide sequence of the RNAi fragment is shown in SEQ ID NO: 1; 转基因三七细胞能合成了竹节参皂苷Ⅳ、竹节参皂苷Ⅳa。Transgenic Panax notoginseng cells can synthesize bamboo ginseng saponin IV and bamboo ginseng saponin IVa.
CN202211106516.5A 2022-09-12 2022-09-12 Method for synthesizing panax japonicus saponins in pseudo-ginseng cells Active CN115725620B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211106516.5A CN115725620B (en) 2022-09-12 2022-09-12 Method for synthesizing panax japonicus saponins in pseudo-ginseng cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211106516.5A CN115725620B (en) 2022-09-12 2022-09-12 Method for synthesizing panax japonicus saponins in pseudo-ginseng cells

Publications (2)

Publication Number Publication Date
CN115725620A CN115725620A (en) 2023-03-03
CN115725620B true CN115725620B (en) 2023-09-15

Family

ID=85293151

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211106516.5A Active CN115725620B (en) 2022-09-12 2022-09-12 Method for synthesizing panax japonicus saponins in pseudo-ginseng cells

Country Status (1)

Country Link
CN (1) CN115725620B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116656727B (en) * 2023-06-12 2024-04-16 昆明理工大学 Preparation method of panax japonicus saponin IVa

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105087599A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjERF1
CN105087601A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjWRKY1
CN105087600A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjbHLH1
CN105441461A (en) * 2016-01-06 2016-03-30 昆明理工大学 Application of panaxnotoginseng transcription factor gene PnWRKY1
CN105441462A (en) * 2016-01-06 2016-03-30 昆明理工大学 Panaxnotoginseng transcription factor gene PnERF1 and application thereof
CN105671159A (en) * 2016-03-01 2016-06-15 中国药科大学 Method for screening notoginsenoside synthesis key genes based on metabolites and gene expression
CN106497939A (en) * 2016-10-14 2017-03-15 昆明理工大学 A kind of Radix Notoginseng transcription factor gene PnMYB1 and its application
CN109295080A (en) * 2018-09-19 2019-02-01 昆明理工大学 The use of ginseng β-arosinol synthase gene Pjβ-AS
CN113265408A (en) * 2021-05-27 2021-08-17 昆明理工大学 Pseudo-ginseng DOF transcription factor genePnDof1And uses thereof
CN113549649A (en) * 2021-08-05 2021-10-26 昆明理工大学 Preparation method of ginsenoside F1
CN113796275A (en) * 2021-09-22 2021-12-17 昆明理工大学 Method for promoting growth of panax notoginseng plant and synthesis of saponin and application thereof
CN114107255A (en) * 2021-11-22 2022-03-01 上海中医药大学 Panax japonicus glycoside hydrolase and application thereof in production of zingiber officinale-shaped notoginsenoside R1
CN115948494A (en) * 2022-09-12 2023-04-11 昆明理工大学 A kind of method utilizing Panax notoginseng cell to synthesize oleanane type saponin
WO2023103365A1 (en) * 2021-12-09 2023-06-15 北京理工大学 Four engineering yeasts capable of efficiently synthesizing intermediate product or end product in synthetic route of ginsenoside ro and method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101788608B1 (en) * 2014-04-30 2017-10-24 한국과학기술원 A novel method for glycosylation of ginsenoside using a glycosyltransferase derived from panax ginseng

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105087599A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjERF1
CN105087601A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjWRKY1
CN105087600A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjbHLH1
CN105441461A (en) * 2016-01-06 2016-03-30 昆明理工大学 Application of panaxnotoginseng transcription factor gene PnWRKY1
CN105441462A (en) * 2016-01-06 2016-03-30 昆明理工大学 Panaxnotoginseng transcription factor gene PnERF1 and application thereof
CN105671159A (en) * 2016-03-01 2016-06-15 中国药科大学 Method for screening notoginsenoside synthesis key genes based on metabolites and gene expression
CN106497939A (en) * 2016-10-14 2017-03-15 昆明理工大学 A kind of Radix Notoginseng transcription factor gene PnMYB1 and its application
CN109295080A (en) * 2018-09-19 2019-02-01 昆明理工大学 The use of ginseng β-arosinol synthase gene Pjβ-AS
CN113265408A (en) * 2021-05-27 2021-08-17 昆明理工大学 Pseudo-ginseng DOF transcription factor genePnDof1And uses thereof
CN113549649A (en) * 2021-08-05 2021-10-26 昆明理工大学 Preparation method of ginsenoside F1
CN113796275A (en) * 2021-09-22 2021-12-17 昆明理工大学 Method for promoting growth of panax notoginseng plant and synthesis of saponin and application thereof
CN114107255A (en) * 2021-11-22 2022-03-01 上海中医药大学 Panax japonicus glycoside hydrolase and application thereof in production of zingiber officinale-shaped notoginsenoside R1
WO2023103365A1 (en) * 2021-12-09 2023-06-15 北京理工大学 Four engineering yeasts capable of efficiently synthesizing intermediate product or end product in synthetic route of ginsenoside ro and method
CN115948494A (en) * 2022-09-12 2023-04-11 昆明理工大学 A kind of method utilizing Panax notoginseng cell to synthesize oleanane type saponin

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Chen,Q..Panax notoginseng dammarane synthetase mRNA, complete cds.Genbank Database.2022,Accession No:由RNAi介导的CAS基因沉默对珠子参皂苷合成的影响. *
Dammarane-type saponins from the leaves of Panax notoginseng and their neuroprotective effects on damaged SH-SY5Y cells;Xin-Yi Liu等;Phytochemistry;第10-17页 *
三七总皂苷生物合成的关键酶及其调控研究进展;赵灿;郭丽娜;彭玉帅;刘辰;王如峰;;中草药(第19期);第 2954-2965页 *
三七细胞中SS、DS共超表达对皂苷合成的影响;杨延;刘迪秋;葛锋;于钢;;现代食品科技(第02期);第7-13页 *
李峰等主编.《中药商品学》.中国医药科技出版社,2014,(第2014年8月第1版),第167-168页"竹节参"部分. *
珠子参中法尼基焦磷酸合酶(FPS)对皂苷生物合成的影响研究;刘美佳;于怡琳;姜森;张翔;刘迪秋;葛锋;;植物研究(第04期);第133-140页 *
由RNAi介导的CAS基因沉默对珠子参皂苷合成的影响;由RNAi介导的CAS基因沉默对珠子参皂苷合成的影响;中国优秀硕士学位论文全文数据库工程科技I辑;B016-308 *

Also Published As

Publication number Publication date
CN115725620A (en) 2023-03-03

Similar Documents

Publication Publication Date Title
CN109295080B (en) The use of ginseng β-arosinol synthase gene Pjβ-AS
CN113549649B (en) Preparation method of ginsenoside F1
CN101487021B (en) Use of miR397 in drought resistance plant cultivation
CN115725620B (en) Method for synthesizing panax japonicus saponins in pseudo-ginseng cells
CN106609267A (en) Application of cucumber CsTTG1 gene to regulating of development of plant epidermal hair, fruit thorns and thorn galls
CN113493795B (en) Preparation method of ginsenoside Rh2
CN105039353A (en) Gene CaMS1 related to chili pollen development and application thereof
CN102226184B (en) Method for cultivating transgenic nitrogen-fixing plants
CN114457094A (en) Peony PoAGL15 gene and amino acid sequence and application thereof
CN102888424A (en) Vegetable binary expression vector pMHZ112 and use thereof
CN102220330A (en) MiRNA-gma-miR56b related to drought resistance of plants and application thereof
CN101445809B (en) Plant binary expression vector for inducing embryoid body formation and plant regeneration, and construction method and application thereof
CN114875039B (en) A kind of method of creating support osmanthus type chrysanthemum
CN105255924A (en) Betula platyphylla cycloartenol synthase gene BPX3 and application for regulation and control of betula platyphylla triterpene content
CN117187297B (en) Method for synthesizing ginsenoside CK in ginseng cells
CN110982921B (en) Application of cymbidium miR159a in accelerating plant life cycle
CN110964724B (en) Application of Chunlan miR390c in enhancing plant cold resistance
CN114478730A (en) Wheat TaVQ14 protein and coding gene and application thereof
CN103695432B (en) A kind of microRNA and application thereof promoting plant nodulation and nitrogen fixation
CN116656727B (en) Preparation method of panax japonicus saponin IVa
CN118185957B (en) PgMYC2 gene for increasing PPD type ginsenoside content in ginseng cells and application thereof
CN113564170B (en) Application of a rice OsmiR156 precursor and its mature body in soybean to improve soybean yield traits
CN117511970A (en) A kind of ginseng PgJOX2 gene induced by coronatine and its application
CN118755679A (en) A cytochrome P450 enzyme and its application
CN106148351A (en) A kind of gene g61 improving Radix Ginseng disease resistance and encoding proteins thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant